NASDAQ:BRLI

Brilliant Acquisition (BRLI) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$3.59
$9.15
50-Day Range
N/A
52-Week Range
N/A
Volume
370,983 shs
Average Volume
87,171 shs
Market Capitalization
$8.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BRLI stock logo

About Brilliant Acquisition Stock (NASDAQ:BRLI)

Brilliant Acquisition Corporation operates as a blank check company. It focuses on acquiring; engaging in share exchange and share reconstruction; purchasing the assets; entering into contractual arrangements; and engaging in similar business combination with one or more businesses. The company was founded in 2019 and is based in Shanghai, China.

BRLI Stock News Headlines

Marriott Bonvoy Brilliant Credit Card Review 2024
Just Released: Insider's Secret to Trading Options
This Surprisingly Simple Formula Can Double Your Money Collecting Consistent Profits From The Stock Market Is More Accessible Than You Think A small group of individuals are using a legitimate yet rarely discussed strategy to generate income from the stock market. They're NOT day traders. And they're NOT Wall Street suits either. I'm talking about normal "working stiffs" and retirees generating steady income from a source that 99% of investors completely overlook. This overlooked income source can be yours today.
Brilliant Acquisition Corp. Rt
Brilliant Acquisition Corp. Wt
Just Released: Insider's Secret to Trading Options
This Surprisingly Simple Formula Can Double Your Money Collecting Consistent Profits From The Stock Market Is More Accessible Than You Think A small group of individuals are using a legitimate yet rarely discussed strategy to generate income from the stock market. They're NOT day traders. And they're NOT Wall Street suits either. I'm talking about normal "working stiffs" and retirees generating steady income from a source that 99% of investors completely overlook. This overlooked income source can be yours today.
BRLI Brilliant Acquisition Corporation
19 brilliant budget beauty buys from £2
See More Headlines
Receive BRLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brilliant Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/18/2014
Today
4/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:BRLI
CUSIP
09057G60
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-970,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($1.89) per share

Miscellaneous

Free Float
548,000
Market Cap
$8.51 million
Optionable
Not Optionable
Beta
-0.12
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

BRLI Stock Analysis - Frequently Asked Questions

How were Brilliant Acquisition's earnings last quarter?

Brilliant Acquisition Co. (NASDAQ:BRLI) announced its quarterly earnings data on Thursday, December, 18th. The medical research company reported $0.66 earnings per share for the quarter, beating the consensus estimate of $0.63 by $0.03. The medical research company had revenue of $227.60 million for the quarter, compared to analyst estimates of $228.81 million. Brilliant Acquisition's revenue for the quarter was up 18.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.40 EPS.

What other stocks do shareholders of Brilliant Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Brilliant Acquisition investors own include OPKO Health (OPK), Arctos NorthStar Acquisition (ANAC), Gentex (GNTX), Halozyme Therapeutics (HALO), Nektar Therapeutics (NKTR), (RAX) (RAX), ACADIA Pharmaceuticals (ACAD), Agios Pharmaceuticals (AGIO), Alnylam Pharmaceuticals (ALNY) and Ambarella (AMBA).

This page (NASDAQ:BRLI) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners